切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ca2 -ATPases - CETP - SMARCA4 - HMG-CoA Reductases

10 件产品

每页
清除全部
  1. PFI 3
    B7744 PFI 3
    Target: Protein polybromo-1|SMARCA4|SMARCA2
    Summary: Polybromo 1和SMARCA4抑制剂
      ≥15.15 mg/mL
      insoluble in H2O
  2. Thapsigargin
    B6614 Thapsigargin
     1 Citation
    中文名: 毒胡萝卜素
    Target: Ca2 -ATPases
    Summary: 肌质网状Ca2+-ATP酶抑制剂
      ≥39.2 mg/mL
      ≥4.12 mg/mL
  3. Mevastatin
    B1788 Mevastatin
    中文名: 美伐他汀
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  4. Simvastatin (Zocor)
    A8522 Simvastatin (Zocor)
    中文名: 辛伐他汀
    Target: HMG-CoA Reductases
    Summary: HMGCR(HMG-CoA还原酶)抑制剂
      ≥20.95 mg/mL
      insoluble in H2O
  5. Pitavastatin Calcium
    A8504 Pitavastatin Calcium
     1 Citation
    中文名: 匹伐他汀钙
    Target: HMG-CoA Reductases
    Summary: 酶HMGCR抑制剂
      ≥34.85 mg/mL
      insoluble in H2O
  6. Evacetrapib (LY2484595)
    A4377 Evacetrapib (LY2484595)
    Target: CETP
    Summary: 强效的CETP选择性抑制剂
      ≥32.1 mg/mL
      insoluble in H2O
  7. Anacetrapib (MK-0859)
    A4375 Anacetrapib (MK-0859)
     1 Citation
    中文名: 安塞曲匹
    Target: CETP
    Summary: RhCETP/突变型 CETP(C13S) 抑制剂
      ≥31.9 mg/mL
      insoluble in H2O
  8. Pravastatin sodium
    A4369 Pravastatin sodium
    中文名: 普伐他汀钠
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶的高选择性和竞争性抑制剂
      ≥13.15 mg/mL
      ≥98.8 mg/mL
  9. Atorvastatin Calcium
    A4367 Atorvastatin Calcium
    中文名: 阿托伐他汀钙
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶抑制剂
      ≥57.75 mg/mL
      insoluble in H2O
  10. Lovastatin
    A4365 Lovastatin
    中文名: 洛伐他汀
    Target: HMG-CoA Reductases
    Summary: HMG-CoA还原酶抑制剂
      ≥20.2 mg/mL
      insoluble in H2O

10 件产品

每页